Literature DB >> 35782815

False Negative Rate of Sentinel Lymph Node Biopsy on Intraoperative Frozen Section in Early Breast Cancer Patients: An Institutional Experience.

Sandhya Gupta1, Geeta Kadayaprath1, Rooma Ambastha2, Shakti Saumnam Shrivastava3.   

Abstract

Sentinel lymph node biopsy is an established practice to avoid axillary clearance, in clinically negative axilla, in breast cancer patients. Sentinel nodes harvested by dual technique, if found negative on intraoperative frozen section, can prevent breast cancer patient from a potentially debilitating complete axillary clearance. Hence, analyzing the institutional accuracy of this technique and comparing it with international standards, becomes important in providing optimal treatment to these patients. A retrospective analysis of all patients who had undergone sentinel lymph node biopsy at our institute from December 2014 to December 2018 was carried out. At our institute, sentinel lymph nodes are identified using dual technique of methylene blue and radiocolloid dye. Intraoperative frozen section of these hot or blue or any enlarged nodes is performed. Patients with positive frozen section undergo complete axillary clearance. All frozen and unfrozen biopsy material is subjected to further paraffin sectioning and immunohistochemistry. False negative rate and factors associated with were analyzed. A total number of 424 patients had undergone intraoperative frozen section for the sentinel node in breast cancer at our institute during the study period. Among these, 307 patients had negative sentinel nodes and 117 had positive sentinel nodes of frozen section. Seventeen patients out of 307 had lymph node metastases in final paraffin report (false negative rate = 12.6%). Two of these were found to have macrometastasis, 13 had micrometastasis and 2 had isolated tumor cells on final immunohistochemistry report. Size of metastases to sentinel lymph node was found to be a statistically significant contributor to higher false negative rate. Sentinel lymph node biopsy using intraoperative frozen section, is a sensitive and specific technique of staging axilla in breast cancer patients. Detection of micrometastasis and isolated tumor cells present a technical challenge and are associated with higher false negative rates. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Breast cancer; False negative rate; Intraoperative frozen section; Sentinel lymph node biopsy

Year:  2021        PMID: 35782815      PMCID: PMC9240165          DOI: 10.1007/s13193-021-01458-7

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  11 in total

1.  Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer.

Authors:  C Chao; S L Wong; D Ackermann; D Simpson; M B Carter; C M Brown; M J Edwards; K M McMasters
Journal:  Am J Surg       Date:  2001-12       Impact factor: 2.565

2.  False negative rate for intraoperative sentinel lymph node frozen section in patients with breast cancer: a retrospective analysis of patients in a single Asian institution.

Authors:  Jolene Wong; Wei Sean Yong; Aye Aye Thike; Jabed Iqbal; Ahmed Syed Salahuddin; Gay Hui Ho; Preetha Madhukumar; Benita Kiat Tee Tan; Kong Wee Ong; Puay Hoon Tan
Journal:  J Clin Pathol       Date:  2015-04-08       Impact factor: 3.411

3.  Intraoperative examination of the sentinel lymph node for breast carcinoma staging.

Authors:  R R Turner; N M Hansen; S L Stern; A E Giuliano
Journal:  Am J Clin Pathol       Date:  1999-11       Impact factor: 2.493

4.  What Is a False Negative Sentinel Node Biopsy: Definition, Reasons and Ways to Minimize It?

Authors:  Kamal Kataria; Anurag Srivastava; Darakhshan Qaiser
Journal:  Indian J Surg       Date:  2016-07-28       Impact factor: 0.656

5.  Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

Authors:  Umberto Veronesi; Giuseppe Viale; Giovanni Paganelli; Stefano Zurrida; Alberto Luini; Viviana Galimberti; Paolo Veronesi; Mattia Intra; Patrick Maisonneuve; Francesca Zucca; Giovanna Gatti; Giovanni Mazzarol; Concetta De Cicco; Dario Vezzoli
Journal:  Ann Surg       Date:  2010-04       Impact factor: 12.969

6.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

7.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

8.  Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?

Authors:  M R Weiser; L L Montgomery; B Susnik; L K Tan; P I Borgen; H S Cody
Journal:  Ann Surg Oncol       Date:  2000-10       Impact factor: 5.344

9.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Authors:  Viviana Galimberti; Bernard F Cole; Stefano Zurrida; Giuseppe Viale; Alberto Luini; Paolo Veronesi; Paola Baratella; Camelia Chifu; Manuela Sargenti; Mattia Intra; Oreste Gentilini; Mauro G Mastropasqua; Giovanni Mazzarol; Samuele Massarut; Jean-Rémi Garbay; Janez Zgajnar; Hanne Galatius; Angelo Recalcati; David Littlejohn; Monika Bamert; Marco Colleoni; Karen N Price; Meredith M Regan; Aron Goldhirsch; Alan S Coates; Richard D Gelber; Umberto Veronesi
Journal:  Lancet Oncol       Date:  2013-03-11       Impact factor: 41.316

10.  Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND).

Authors:  Oreste Gentilini; Umberto Veronesi
Journal:  Breast       Date:  2012-07-25       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.